Iloperidone
| Clinical data | |
|---|---|
| Trade names | Fanapt, Zomaril |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a609026 |
| License data |
|
| Routes of administration | By mouth, injection |
| Drug class | Atypical antipsychotic |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 96% (oral; Tmax = 2–4 hours) |
| Protein binding | ~97% |
| Metabolism | Hepatic (CYP2D6-mediated hydroxylation and CYP3A4-mediated O-demethylation) |
| Elimination half-life | 18–33 hours |
| Excretion | urine (45.1–58.2%) and feces (19.9–22.1%) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.106.441 |
| Chemical and physical data | |
| Formula | C24H27FN2O4 |
| Molar mass | 426.488 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
Iloperidone, sold under the brand name Fanapt among others, is an atypical antipsychotic for the treatment of schizophrenia and bipolar I disorder.